Dennis Niebel, Dagmar Wilsmann-Theis, Thomas Bieber, Mark Berneburg, Joerg Wenzel, & Christine Braegelmann. (2022). Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation. MDPI AG.
Chicago Style (17th ed.) CitationDennis Niebel, Dagmar Wilsmann-Theis, Thomas Bieber, Mark Berneburg, Joerg Wenzel, and Christine Braegelmann. Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation. MDPI AG, 2022.
MLA (9th ed.) CitationDennis Niebel, et al. Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.